title: Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
authors: Unité d'Hémostase Clinique, CHU de Lyon, Lyon, France.
authors: Y
authors: Y
authors: Chevalier
authors: G
authors: G
authors: Mandrillon
authors: A
authors: A
authors: Bestion
authors: J C
authors: JC
authors: Lega
authors: P
authors: P
authors: Piquet
authors: J
authors: J
authors: Ninet
authors: Y
authors: Y
authors: Dargaud
mesh_terms: D000328:Adult; D005165:Factor V / Q000235:genetics*; D005260:Female; D005602:France / Q000453:epidemiology; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010641:Phenotype; D011237:Predictive Value of Tests; D011516:Prothrombin / Q000235:genetics*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D012189:Retrospective Studies; D012307:Risk Factors; D036542:Tomography, Spiral Computed; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*; D020246:Venous Thrombosis / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics*
chemical_list: C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin